Literature DB >> 7161034

Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979).

L Pinessi, L Bergamini, R Cantello, C Di Tizio.   

Abstract

A descriptive epidemiological survey of Myotonia Congenita (MC) and Myotonic Dystrophy (MD) was carried out on the resident population of the City of Turin, Italy. Cases were collected from the Archives of the Neurological Clinic, University of Turin, and from other neurological departments in the city's hospitals. Every patient (and the "healthy" relatives of MD subjects) underwent clinical and EMG re-examination, in order to confirm the initial diagnosis and to investigate the familial distribution of the diseases. The point prevalence rate was 0.9 (+/- 0.6) X 10(-5) for MC and 2.1 (+/- 0.8) X 10(-5) for MD. During the period 1955-1979 the mean annual incidence was 0.3 (+/- 0.2) X 10(-6) for MC and 0.7 (+/- 0.3) X 10(-6) for MD. The incidence-at-birth rate was 1.4 (+/- 1.2) X 10(-5) for MC and 2.9 (+/- 1.8) X 10(-5) for MD. The modalities of inheritance and sex distribution of MC and MD were also studied. Knowledge of epidemiological features of these myopathies is of vital importance for genetic counselling.

Entities:  

Mesh:

Year:  1982        PMID: 7161034     DOI: 10.1007/bf02043311

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  8 in total

1.  Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota.

Authors:  L T KURLAND
Journal:  J Chronic Dis       Date:  1958-10

2.  Dystrophia myotonica with special reference to Northern Ireland.

Authors:  M LYNAS
Journal:  Ann Hum Genet       Date:  1957-06       Impact factor: 1.670

3.  On the classification, natural history and treatment of the myopathies.

Authors:  J N WALTON; F J NATTRASS
Journal:  Brain       Date:  1954       Impact factor: 13.501

4.  Neurological disease in an English city.

Authors:  M Brewis; D C Poskanzer; C Rolland; H Miller
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

5.  Early recognition of heterozygotes for the gene for dystrophia myotonica.

Authors:  S Bundey; C O Carter; J F Soothill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

6.  [Segregation analysis of myotonia atrophica].

Authors:  A Todorov; M Jéquier; D Klein; N E Morton
Journal:  J Genet Hum       Date:  1970-12

7.  Myotonic dystrophy: opportunities for prenatal prediction.

Authors:  H G Schrott; G S Omenn
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

8.  Genetic approaches to the nosology of muscular disease: myotonias and similar diseases.

Authors:  P E Becker
Journal:  Birth Defects Orig Artic Ser       Date:  1971-02
  8 in total
  9 in total

1.  Myotonia congenita in northern Finland: an epidemiological and genetic study.

Authors:  P Baumann; V V Myllylä; J Leisti
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

2.  Congenital myotonic dystrophy.

Authors:  S Gulati; M Kabra; S Gera; V Kalra; R Saxena; I C Verma
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

3.  Clinical Utility Gene Card for: autosomal dominant myotonia congenita (Thomsen Disease).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-04-26       Impact factor: 4.246

4.  Treatment and management of neuromuscular channelopathies.

Authors:  Lydia Sharp; Jaya R Trivedi
Journal:  Curr Treat Options Neurol       Date:  2014-10       Impact factor: 3.598

5.  Nondystrophic myotonia: challenges and future directions.

Authors:  Jaya R Trivedi; Stephen C Cannon; Robert C Griggs
Journal:  Exp Neurol       Date:  2013-12-18       Impact factor: 5.330

Review 6.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

7.  Moroccan consanguineous family with Becker myotonia and review.

Authors:  Ilham Ratbi; Siham Chafai Elalaoui; Adela Escudero; Yamina Kriouile; Jesus Molano; Abdelaziz Sefiani
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

8.  Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.

Authors:  Celine Dogan; Marie De Antonio; Dalil Hamroun; Hugo Varet; Marianne Fabbro; Felix Rougier; Khadija Amarof; Marie-Christine Arne Bes; Anne-Laure Bedat-Millet; Anthony Behin; Remi Bellance; Françoise Bouhour; Celia Boutte; François Boyer; Emmanuelle Campana-Salort; Françoise Chapon; Pascal Cintas; Claude Desnuelle; Romain Deschamps; Valerie Drouin-Garraud; Xavier Ferrer; Helene Gervais-Bernard; Karima Ghorab; Pascal Laforet; Armelle Magot; Laurent Magy; Dominique Menard; Marie-Christine Minot; Aleksandra Nadaj-Pakleza; Sybille Pellieux; Yann Pereon; Marguerite Preudhomme; Jean Pouget; Sabrina Sacconi; Guilhem Sole; Tanya Stojkovich; Vincent Tiffreau; Andoni Urtizberea; Christophe Vial; Fabien Zagnoli; Gilbert Caranhac; Claude Bourlier; Gerard Riviere; Alain Geille; Romain K Gherardi; Bruno Eymard; Jack Puymirat; Sandrine Katsahian; Guillaume Bassez
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

Review 9.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.